NCT01177293View on ClinicalTrials.gov

Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

Amlodipine - reference

Amlodipine capsule, 10 mg, single dose, with water

DRUG

Amlodipine ODT - test

Amlodipine orally disintegrating tablet (ODT), 10 mg, single dose, without water

Trial Locations (1)

500 050

Pfizer Investigational Site, Hydrabad

Sponsors

Collaborators (1)

Aurobindo Pharma Ltd
All Listed Sponsors
collaborator

Aurobindo Pharma Ltd

INDUSTRY

collaborator

Trident Life Sciences Ltd.

INDUSTRY

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01177293 - Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules | Biotech Hunter | Biotech Hunter